OCGN stock has suffered as a Covid-19 vaccine latecomer, but news that Covaxin won emergency approval in India sent shares soaring. More
Articles
No Passengers Needed to Ride with Electrameccanica Vehicles
SOLO stock has been stuck in third gear lately, but the urban driving experience is quickly evolving with new EV commercial deliveries. More
Recent Weakness May Mean Opportunity With Moderna Stock
If you already own MRNA stock, it's too early to sell. If you do not yet own it? It's not too late to buy. More
Cannabis Stocks: Why CGC, TLRY, SNDL, CRON Stocks Are Getting High Today
New York and California have both ruled in favor of pro-cannabis policies. The future is looking green for cannabis stocks. More
When Facing a Sell-Off, This Is the First Thing You Should Do
Cash is the one and only infallible hedge against loss. It may not be the most exciting asset in the world, but it's one you need to have. More
Opendoor Could Rise 44% Higher Given Its Huge Inventory of Homes
Opendoor still looks like good value despite its recent rise. OPEN stock is worth up to 44% more at $34.65 using 15 times expected profits on its present inventory balance over the next 3 years. More
